A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-54175446 in Healthy Male Participants

NCT02515955 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
76
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Janssen-Cilag International NV